• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Point of Care Diagnostics Testing Market Size

    ID: MRFR/HC/9161-HCR
    120 Pages
    Rahul Gotadki
    October 2025

    Point of Care Diagnostics Testing Market By Product (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing, Coagulation Monitoring, Pregnancy & Fertility Testing, Hematology Testing, Cancer/Tumor Marker Testing, Urinalysis Testing, Cholesterol, Drugs-of-Abuse Testing), By End User (Hospitals & Clinics, Diagnostic Centers, Homecare/Self Testing), By Mode of Purchase...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Point of Care Diagnostics Testing Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Point Of Care Diagnostics Testing Size

    Point of Care Diagnostics Testing Market Growth Projections and Opportunities

    The size of the market for point-of-care diagnostics/testing is at a CAGR of 11.5% with USD 19.12 Billion over the forecast period from 2022 to 2030. The market is driven by several factors that together define its outline and growth trajectory. One such major force driving this paradigm shift is an increased focus on personalized and patient-centric healthcare service delivery models. Point-of-care-diagnostic testing, as a rapid and decentralized test, goes along with the changing norm of providing accurate information when needed by patients. Technological advances are important influencers in shaping the POC diagnostic market. Innovations in diagnostic technologies like biosensors, molecular diagnostics, and portable imaging devices contribute to the development of faster and more accurate point-of-care test tools. Diagnostic devices are being made smaller while lab-on-a-chip technologies have been employed, leading to tests being carried out outside typical laboratories. Epidemiological factors also influence the demand for points-of-care diagnostics solutions. Infectious disease prevalence; increasing burden of chronic conditions like diabetes, hypertension, etc.; rapid screening required in emergency/urgent care settings drive adoption of POC testing solutions. Point Of Care Diagnostics Market depends on regulatory frameworks, and approval processes are key influences. Stringent adherence to regulatory standards ensures the safety & efficacy of such devices in POCT applications; Regulatory approvals must be secured for entry into the place requiring complex process navigation for companies before commercialization can take place through their products; Getting permissions from national regulators around the world has never been easy. The adoption rate for point-of-care diagnostics is significantly influenced by economic factors such as cost-effectiveness and affordability. Global collaboration on health infrastructure will support expansion in point-of-care diagnostics markets. It would be easy to integrate PoC diagnostics globally if governments collaborated with international organizations as well as industry players themselves. Market dynamics for the Point Of Care Diagnostics Market include competition and consolidation among companies. The landscape of this field is characterized by major players, the entry of new firms, and strategic alliances, among other factors, for market participants such as manufacturers; product portfolio expansion and company strengthening are done through acquisitions, mergers, and research partnerships.

    Point of Care Diagnostics Testing Market Size Graph

    Market Summary

    The Global Point of Care Diagnostics Testing Market is projected to experience substantial growth from 57.7 USD Billion in 2024 to 157.9 USD Billion by 2032.

    Key Market Trends & Highlights

    Point of Care Diagnostics Testing Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate of 9.58 percent from 2024 to 2032. By 2032, the market valuation is anticipated to reach 157.9 USD Billion, indicating a robust expansion. In 2024, the market is valued at 57.7 USD Billion, reflecting a strong foundation for future growth. Growing adoption of point of care diagnostics due to increasing demand for rapid and accurate testing is a major market driver.

    Market Size & Forecast

    2024 Market Size 57.7 (USD Billion)
    2032 Market Size 157.9 (USD Billion)
    CAGR (2024-2032) 9.58%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Abbott Laboratories (US), Chembio Diagnostics, Inc. (US), Hoffmann-La Roche Ltd (Switzerland), Johnson &amp; Johnson Services, Inc. (US), Siemens Healthineers GmbH (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), Instrumentation Laboratory Company (Werfen) (US), EKF Diagnostics Holdings plc (UK)</p>

    Market Trends

    Drivers

    Increasing demand for COVID-19 POC test kits

    <p>The Global Point of Care Diagnostics Testing Market is poised for substantial growth, driven by advancements in technology and an increasing demand for rapid diagnostic solutions in various healthcare settings.</p>

    U.S. Food and Drug Administration (FDA)

    Point of Care Diagnostics Testing Market Market Drivers

    Market Trends and Projections

    Government Initiatives and Funding

    Government initiatives and funding significantly impact the Global Point of Care Diagnostics Testing Market Industry, as various health authorities recognize the importance of accessible diagnostic solutions. Investments in point-of-care technologies are being prioritized to improve healthcare delivery, particularly in underserved regions. Programs aimed at enhancing diagnostic infrastructure and training healthcare professionals are being implemented globally. These initiatives not only foster innovation but also encourage collaboration between public and private sectors, ultimately driving market growth. As governments continue to support point-of-care diagnostics, the industry is poised for expansion, aligning with global health objectives.

    Shift Towards Home Healthcare Services

    The Global Point of Care Diagnostics Testing Market Industry is witnessing a notable shift towards home healthcare services, driven by the increasing preference for at-home testing and monitoring. Patients are increasingly opting for convenient testing options that allow them to manage their health from the comfort of their homes. This trend is supported by advancements in telemedicine and mobile health technologies, which facilitate remote consultations and data sharing. As a result, the market is likely to expand, with projections indicating a compound annual growth rate of 9.58% from 2025 to 2035, reflecting the growing acceptance of home-based diagnostic solutions.

    Increasing Prevalence of Chronic Diseases

    The Global Point of Care Diagnostics Testing Market Industry is significantly influenced by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and infectious diseases. As these conditions require continuous monitoring and management, point-of-care testing offers a practical solution for patients and healthcare providers. The ability to conduct tests in various settings, including home care and remote locations, enhances patient compliance and engagement in their health management. This trend is expected to propel market growth, as the demand for accessible and efficient diagnostic solutions continues to rise in response to the global health landscape.

    Rising Demand for Rapid Testing Solutions

    The Global Point of Care Diagnostics Testing Market Industry experiences a surge in demand for rapid testing solutions, driven by the need for timely diagnosis and treatment. Healthcare providers increasingly prefer point-of-care testing due to its ability to deliver results within minutes, facilitating quicker clinical decisions. This trend is particularly evident in emergency departments and outpatient settings, where immediate test results can significantly impact patient outcomes. The market is projected to reach 57.7 USD Billion in 2024, reflecting a growing recognition of the value of rapid diagnostics in enhancing healthcare efficiency and patient care.

    Technological Advancements in Diagnostic Devices

    Technological innovations play a crucial role in the Global Point of Care Diagnostics Testing Market Industry, with advancements in microfluidics, biosensors, and mobile health applications enhancing diagnostic capabilities. These technologies enable the development of more accurate, user-friendly, and portable testing devices. For instance, the integration of artificial intelligence in diagnostic tools is streamlining data analysis and improving result accuracy. As these technologies evolve, they are expected to drive market growth, contributing to an anticipated increase in market value to 157.9 USD Billion by 2035, as healthcare systems worldwide adopt more sophisticated point-of-care solutions.

    Market Segment Insights

    Point of Care Diagnostics Testing Product Insights

    Point of Care Diagnostics Testing End User Insights

    Point of Care Diagnostics Testing Mode of Purchase Insights

    Point of Care Diagnostics Testing Platform Insights

    Get more detailed insights about Point of Care Diagnostics Testing Market Research Report - Global Forecast till 2032

    Regional Insights

    Key Companies in the Point of Care Diagnostics Testing Market market include

    Industry Developments

    • In June 2021,DCN Dx(US) acquired the pointofcare diagnostics development company PortaScience Inc. (US). This acquisition will expand the point of care product portfolio of the company.
    • In April 2021,the Indian Institute of Technology Kharagpur (India), an Indian engineering institute,launched a nucleic acid-based pointof care diagnostic devicefor COVID-19 diagnosis.
    • In April 2021,LumiraDx (US), a next-generation point of care diagnostics testing company,announced its merger with CA Healthcare Acquisition (CAHC) (US)in a deal worth USD 5 billion.
    • In March 2021, MatMaCorp (US) launched MYRTA, a handheld real-time POCPCR device for molecular diagnostics.
    • In March 2020, Abbott(US) launched the fastest available molecular pointofcare test to detect the coronavirus in less than 5 minutes.

    Future Outlook

    Point of Care Diagnostics Testing Market Future Outlook

    <p>The Global Point of Care Diagnostics Testing Market is projected to grow at a 9.58% CAGR from 2024 to 2032, driven by technological advancements, increasing demand for rapid testing, and rising healthcare expenditures.</p>

    New opportunities lie in:

    • <p>Develop portable diagnostic devices for remote healthcare settings. Invest in AI-driven analytics for enhanced diagnostic accuracy. Expand partnerships with telehealth platforms to integrate testing solutions.</p>

    <p>By 2035, the market is expected to achieve substantial growth, reflecting a robust demand for innovative diagnostic solutions.</p>

    Market Segmentation

    Point of Care Diagnostics Testing Product Outlook

    • {""=>["Strips"
    • "Meters"
    • "Lancets"]}
    • {""=>["Cardiac Marker Testing Products"
    • "Blood Gas/Electrolyte Testing Products"
    • "HbA1c Testing Products"]}
    • {""=>["HIV Testing  "
    • "Respiratory Infection Testing"
    • "Hepatitis Testing"
    • "Sexually Transmitted Disease Testing"
    • "Others"]}
    • {""=>["PT/INR Testing"
    • "ACT/APTT Testing"]}

    Point of Care Diagnostics Testing End User Outlook

    • Hospitals & Clinics
    • Diagnostic Centers
    • Homecare/Self Testing
    • Others

    Point of Care Diagnostics Testing Platform Outlook

    • Immunoassays
    • Molecular Diagnostics
    • Dipsticks
    • Others

    Point of Care Diagnostics Testing Mode of Purchase Outlook

    • OTC Testing Products
    • Prescription-based testing products

    Report Scope

    Report Attribute/MetricDetails
    Market Size 202352.70 (USD Billion)
    Market Size 202457.71 (USD Billion)
    Market Size 2032119.36 (USD Billion)
    Compound Annual Growth Rate (CAGR)9.77 % (2024 - 2032)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2023
    Market Forecast Period2024 - 2032
    Historical Data2018-2022
      Geographies Covered  North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors  Abbott Laboratories (US),Siemens Healthineers GmbH (Germany),Chembio Diagnostics, Inc.(US),Hoffmann-La Roche Ltd (Switzerland),Johnson & Johnson Services, Inc. (US),Becton, Dickinson and Company (US),Danaher Corporation (US),PTS Diagnostics (US),Nova Biomedical (US),QuidelCorporation (US)
      Key Market Opportunities  Increasing healthcare issues increasing population diagnosed
      Key Market Drivers  Increasing demand for COVID-19 POC test kits Risingnumber of chronic disease cases across the globe

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the CAGR for Point of Care Diagnostics Testing Market?

    The Point of Care Diagnostics/Testing Market can expand at 9.77% CAGR by 2032.

    Who are key players of the Point of Care Diagnostics Testing Market?

    Abbott Laboratories (US),Siemens Healthineers GmbH (Germany),Chembio Diagnostics, Inc.(US),Hoffmann-La Roche Ltd (Switzerland),Johnson &amp; Johnson Services, Inc. (US),Becton, Dickinson and Company (US),Danaher Corporation (US),PTS Diagnostics (US),Nova Biomedical (US),QuidelCorporation (US) Are the key players of market

    What is the valuation of the Point of Care Diagnostics Testing Market?

    By 2032, the Point of Care Diagnostics/Testing Market value can exceed USD 119.36 Billion.

    What is the Point of Care Diagnostics Testing Market driver?

    Increasing demand for COVID-19 POC test kits is driving the Point of Care Diagnostics/Testing Market.

    What is the Point of Care Diagnostics Testing Market restrain?

    Increases the potential of rapid medical diagnosis restrain the Point of Care Diagnostics/Testing Market.

    1. REPORT PROLOGUE
    2. MARKET INTRODUCTION
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    3. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
        1. Primary Interviews and Information Gathering Process
        2. Breakdown of Primary Respondents
      5. Forecasting Cellulite Type
      6. Market Size Estimation
        1. Bottom-Up Approach
        2. Top-Down Approach
      7. Data Triangulation
      8. Validation
    4. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    5. MARKET FACTOR ANALYSIS
      1. Porter’s Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Value Chain Analysis
      3. COVID-19 Impact Analysis
        1. Market Impact Analysis
        2. Impact on Supply Chain
        3. Regional Impact
        4. Opportunity and Threat Analysis
    6. GLOBAL Point of Care Diagnostics Testing MARKET, BY PRODUCT
      1. Overview
      2. Glucose Monitoring
        1. Strips
        2. Meters
        3. Lancets
      3. Cardiometabolic Monitoring
        1. Cardiac Marker Testing Products
        2. Blood Gas/Electrolyte Testing Products
        3. HbA1c Testing Products
      4. Infectious Disease Testing
        1. HIV Testing
        2. Respiratory Infection Testing
        3. Hepatitis Testing
        4. Sexually Transmitted Disease Testing
        5. Others
      5. Coagulation Monitoring
        1. PT/INR Testing
        2. ACT/APTT Testing
      6. Pregnancy & Fertility Testing
      7. Hematology Testing
      8. Cancer/Tumor Marker Testing
      9. Urinalysis Testing
      10. Cholesterol
      11. Drugs-of-Abuse Testing
      12. Others
    7. GLOBAL Point of Care Diagnostics Testing MARKET, BY END USER
      1. Overview
      2. Hospitals & Clinics
      3. Diagnostic Centers
      4. Homecare/Self Testing
      5. Others
    8. GLOBAL Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE
      1. Overview
      2. OTC Testing Products
      3. Prescription-based testing products
    9. GLOBAL Point of Care Diagnostics Testing MARKET, BY PLATFORM
      1. Overview
      2. Immunoassays
      3. Dipsticks
      4. Molecular Diagnostics
      5. Others
    10. GLOBAL Point of Care Diagnostics Testing MARKET, BY REGION
      1. Overview
      2. North America
        1. US
        2. Canada
      3. Europe
        1. Germany
        2. France
        3. UK
        4. Italy
        5. Spain
        6. Rest of Europe
      4. Asia-Pacific
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
      5. Rest of the World
        1. Middle East
        2. Africa
        3. Latin America
    11. COMPANY LANDSCAPE
      1. Overview
      2. Competitive Analysis
      3. Market Share Analysis
      4. Major Growth Strategy in the Global Point of Care Diagnostics Testing Market
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Global Point of Care Diagnostics Testing Market
      7. Key developments and Growth Strategies
        1. New ProductLaunch/Service Deployment
        2. Merger &Acquisitions
        3. Joint Ventures
      8. Major Players Financial Matrix
        1. Sales & Operating Income, 2020
        2. Major Players R&D Expenditure, 2020
    12. COMPANY PROFILES
      1. Abbott Laboratories
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. Siemens Healthineers GmbH
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      3. Chembio Diagnostics, Inc.
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      4. F. Hoffmann-La Roche Ltd
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      5. Johnson & Johnson Services, Inc.
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      6. Becton, Dickinson and Company
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      7. Danaher Corporation
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      8. PTS Diagnostics
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      9. Nova Biomedical
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      10. Quidel Corporation
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      11. Sekisui Diagnostics
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      12. Trinity Biotech
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      13. AccuBioTech Co., Ltd.
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      14. Instrumentation Laboratory Company (Werfen)
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      15. EKF Diagnostics Holdings plc
        1. Company Overview
        2. Product Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
    13. APPENDIX
      1. References
      2. Related Reports

    Point of Care Diagnostics Testing Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials